Beijing Beilu Pharmaceutical Co., Ltd (SHE:300016)

Sage Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,113	3,050	3,503	3,208	4,523	4,727
Market Cap Growth	34.72%	-12.92%	9.20%	-29.09%	-4.32%	6.30%
Enterprise Value	5,472	3,388	3,635	3,239	4,391	4,697
Last Close Price	9.44	6.15	7.07	6.40	8.92	9.23
PE Ratio	257.89	223.42	-	284.26	36.04	27.06
Forward PE	-	19.22	19.22	19.22	19.22	19.22
PS Ratio	4.83	3.10	3.93	4.19	5.26	5.71
PB Ratio	2.77	1.67	1.96	1.67	2.17	2.50
P/TBV Ratio	3.46	2.09	2.30	1.98	2.71	3.05
P/FCF Ratio	106.50	49.49	-	128.15	-	1211.38
P/OCF Ratio	29.72	18.71	59.91	25.10	41.60	26.86
EV/Sales Ratio	5.17	3.45	4.08	4.23	5.11	5.68
EV/EBITDA Ratio	37.26	23.62	64.58	46.41	23.08	26.09
EV/EBIT Ratio	108.33	63.64	-	-	34.43	34.20
EV/FCF Ratio	113.98	54.97	-	129.42	-	1203.59
Debt / Equity Ratio	0.56	0.44	0.44	0.34	0.28	0.37
Debt / EBITDA Ratio	7.03	5.41	13.30	8.92	3.02	3.91
Debt / FCF Ratio	21.51	12.94	-	25.84	-	180.17
Asset Turnover	0.35	0.34	0.32	0.27	0.30	0.37
Inventory Turnover	1.94	1.73	1.86	1.39	1.79	2.34
Quick Ratio	1.79	1.74	2.63	2.93	3.65	3.55
Current Ratio	2.51	2.57	3.33	3.89	4.57	3.93
Return on Equity (ROE)	0.11%	0.01%	-4.49%	-0.23%	5.54%	9.21%
Return on Assets (ROA)	1.04%	1.15%	-0.55%	-0.11%	2.77%	3.84%
Return on Capital (ROIC)	1.14%	1.28%	-0.61%	-0.12%	3.03%	4.24%
Return on Capital Employed (ROCE)	1.90%	2.10%	-	-	4.90%	5.50%
Earnings Yield	0.33%	0.45%	-2.05%	0.35%	2.77%	3.70%
FCF Yield	0.94%	2.02%	-2.46%	0.78%	-0.86%	0.08%
Dividend Yield	0.53%	0.81%	-	1.09%	0.78%	0.65%
Payout Ratio	123.88%	153.09%	-	465.63%	35.77%	23.77%
Buyback Yield / Dilution	4.80%	4.88%	15.21%	-16.87%	0.52%	0.80%
Total Shareholder Return	5.33%	5.69%	15.21%	-15.78%	1.31%	1.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.